Introduction
============

Skin cancer is the most common form of cancers with increasing rate per year especially in fair skin population. Non-melanoma skin cancers account for about half of all cancers and include basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) \[[@B1]\]. "Current diagnostic methods for skin cancers rely on physical examination of lesions in conjunction with skin biopsy, which involves the removal of tissue samples from the body for examination. Biopsy of large lesions often requires substantial tissue removal. Though this protocol for skin lesion diagnosis has been accepted as the golden standard, it is subjective, invasive, time-consuming and painful. Laboratory results for the determination of histopathology of a suspected tumor may generally take several days. Since suspicious areas are identified by visual inspection alone, there are a significant number of false positives that undergo biopsy. Conversely, many malignant lesions can also be overlooked. There is an urgent need for objective criteria that would aid the clinician in evaluating whether biopsy is required" \[[@B2]\].

Now a days there is a growing demand for accurate and fast models to predict the light distribution in biological tissues to deduce their optical properties from the measurable quantities \[[@B3]\]. One of the measurable quantities is the diffuse reflectance, it is a function of the distance between the observation point and the incident point of a laser beam. The diffuse reflectance is defined as the photon probability of re-emission from inside a semi-infinite turbid medium per unit surface area (skin tissue). Measurements of the diffuse reflectance can be used to determine the optical properties of tissue non-invasively \[[@B3]\].

Biological scatterers are primarily cell nuclei and mitochondria, with diameters ranging from 1 *μm* to 8 *μm*. As the laser light wavelength is smaller than these scatterers, therefore the light interaction can be predicted by Mie scattering theory, which is an exact analytical solution of Maxwell's electromagnetic field equations, but when the scattering particles are much smaller than the wavelength, the light interaction can be predicted by Raleigh scattering theory, which is a limiting case of Mie theory. Scattering coefficient is defined as the probability of photon scattering per unit infinitesimal path length \[[@B4]\].

In this paper we present a design and implementation of a non-invasive, painless and fast method to deduce the optical properties of skin cancerous suspicion lesions based on the application of the oblique incidence diffused reflectance reflectometry (OIDR) as originally conceived by Wang and Jacques \[[@B5],[@B6]\].

The images of the diffused reflectance for both lesion and healthy adjacent skins of the same patient are captured by a CCD camera, these images are then analyzed and processed by a specially written Matlab program v.10 to perform a logical prediction (diagnosis) for the examined lesion for squamous and basal cancerous cells.

Materials and methods
=====================

Patients studied
----------------

SCC and BCC are types of non-melanoma skin cancer that chosen by Research Section of Medical Engineering / College of Engineering / Al-Nahrain University.

Fifty patients are selected under supervision of Dermatology Consultant Section of The Governmental Marjan Teaching Hospital / MOH -- Iraq. Dermatologist identify suspicious skin lesion that were going to be biopsied for routine care. Patients were asked to participate in the study and sign on informed consent approved by the Babylon Health Directorate / MOH -- Iraq.

The needed data from each patient were collected, analyzed and recorded before physicians removed the lesion and sent it for biopsy. Histopathological diagnoses was performed by the specialized laboratory of Marjan Teaching Hospital and reported within 6 to 7 days to compare with our recorded logic predicted result.

Oblique incidence diffused reflectance method
---------------------------------------------

The significant changes that happen in malignant cells make it optically differentiable from benign cells due to the enlargement in their cell nuclei and mitochondria sizes, it is important to know that the nuclei and mitochondria are the major scatterers in the cells, therefore the enlargement of their size considered as the important indicator to the presence of cancer cells that cause increase in light scattering \[[@B4],[@B7]\].

When a light enters a semi-infinite tissue, it will generally scatter many times before either being absorbed or escaping the tissue surface at a point other than its point of entry. The multiple scattered light that escapes is called diffuse reflectance \[[@B8],[@B9]\], as seen in Figure [1](#F1){ref-type="fig"}.

![**Light interaction in a scattering and absorbing media**\[[@B10]\] .](1475-925X-11-88-1){#F1}

Because it is easier to model isotropic scattering than anisotropic scattering, the reduced or transport scattering coefficient μ~s~\' is introduced as the equivalent isotropic scattering coefficient of an anisotropically scattering medium. μ~s~\'=μ~s~ (1 -- g), where μ~s~ is the scattering coefficient and g is the average cosine of the scattering angle \[[@B8],[@B11]\]:

A sketch for the laser oblique incidence diffuse reflectance pattern from a semi-infinite turbid medium like the biological tissue is shown in Figure [2](#F2){ref-type="fig"}.

![**Single wavelength oblique incidence diffuse reflectance pattern**\[[@B10]\] .](1475-925X-11-88-2){#F2}

The spatial distribution of diffuse reflectance of an oblique incident laser beam from a semi-infinite turbid medium like the biological tissue has been modeled according to Wang and Jacques by two isotropic point sources; one positive source located below the tissue surface and one negative image source above the tissue surface, as shown in Figure [3](#F3){ref-type="fig"}. The positive source is buried at distance (*d*~*s*~) from the point of laser incidence on the skin, this distance is considered practically to be three times greater than the diffusion coefficient "D" as in the mean free path Eq.(1) \[[@B6],[@B11],[@B12]\]:

$$1mef = d_{s} = 3D = \frac{1}{0.35\mu_{a} + \mu_{s}^{'}}$$

![**Schematic representation of obliquely incident light**\[[@B6]\] .](1475-925X-11-88-3){#F3}

The modified dipole source diffusion theory model gives diffuse reflectance at the skin boundary R(x), by using Eq.(2) which can be scaled to fit a relative reflectance profile that is in absolute units \[[@B6]\].

$$R\left( x \right) = \frac{1}{4\pi}\left\lbrack {\frac{\Delta z\left( {1 + \mu_{\mathit{eff}}\rho_{1}} \right)}{\rho_{1}^{3}} + \frac{\left( {\Delta z + 2z_{b}} \right)\left( {1 + \mu_{\mathit{eff}}\rho_{2}} \right)\exp\left( {- \mu_{\mathit{eff}}\rho_{2}} \right)}{\rho_{2}^{3}}} \right\rbrack$$

Where ;

α~i~ : is the angle between the incident laser beam and the normal line on the tissue surface.

α~t~ : is the angle of light transmission into the tissue, could be calculated according to Snell's law which is used to measure the new optical path where the isotropic positive point is locate. as seen in Figure [3](#F3){ref-type="fig"}.

r : is the distance between the normal line between the positive and negative point and the observation point.

*x* : is the distance between the point of observation and the point of light incidence (origin point).

*ρ*~*1*~, *ρ*~*2*~ : are the distances from the two point sources to the point of interest.

z~b~ : is the distance between the virtual boundary and the surface of the tissue.

*A* : is the parameter related to the internal reflection which can be calculated using either Fresnel reflection coefficients or using empirical variable *r*~*i*~ and relative reflection coefficient *n*~*rel*~ of the tissue ambient (air) interface as following \[[@B8]\]:

$$n_{\mathit{rel}} = n_{\mathit{tissue}}/n_{\mathit{ambint}}$$

$$r_{i} = - 1.440n_{\mathit{rel}}^{- 2} + 0.710n_{\mathit{rel}}^{- 1} + 0.668 + 0.0636n_{\mathit{rel}}$$

$$A = \frac{1 + r_{i}}{1 - r_{i}}$$

*A* : is unity for a matched boundary \[[@B8]\].

Δ*z* : is the depth of the positive point source from the surface of skin.

$$\Delta z = \frac{\cos\left( a_{t} \right)}{\mu_{a} + \mu_{s}'} = \Delta x\mspace{2mu} tan^{- 1}\left( a_{t} \right)$$

Δx : is the distance shift between the point of laser incidence and the center of the most symmetrical circle, as seen in Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}.

$$\Delta x = \frac{sin\mspace{2mu} a_{t}}{0.35\mu_{a} + \mu_{s}^{'}}$$

![**Oblique incidence diffuse reflectance curve along the x direction**\[[@B10]\] .](1475-925X-11-88-4){#F4}

Ones the distance shift (Δx) was found, the diffusion coefficient D could be calculated from Eq.(8) \[[@B6]\]:

$$D = \frac{\Delta x}{3\mspace{2mu} sin\left( a_{t} \right)}$$

μ~*eff*~ is the effective attenuation coefficient \[[@B6]\]:

$$\mu_{\mathit{eff}} = \sqrt{\frac{\mu_{a}}{D}}$$

The μ~*eff*~ value could be found by using a least-square fitting to Eq.(2).

Now it is possible to find the skin optical properties μ~s~\' and μ~a~ from Eqs.(10 and 11) as following \[[@B6]\] :

$$\mu_{a} = \frac{\mu_{\mathit{eff}}^{2} \ast \Delta x}{3\sin\left( a_{t} \right)}$$

and

$$\mu_{s}^{'} = \frac{\sin\left( a_{t} \right)}{\Delta x} - 0.35 \ast \mu_{a}$$

Experimental work
=================

Experimental setup
------------------

The oblique incidence diffused reflectance reflectometry (OIDR) system that is designed in this work to measure the skin optical properties is sketched in Figure [5](#F5){ref-type="fig"}. It includes the following components:

1\. 650 *nm* laser diode continuous source, DILAS diode laser company.

2\. Multimode fiber optic of 0.22 NA and 200 μm in diameter, fitted by a guiding needle at 45^o^ angle with the central normal imaginary line of CCD camera.

3\. Charge coupled device (CCD) camera, model F-068D / Delon.

4\. Computer with special written analytical Matlab program v.10.

![**Schematic sketch of OIDR setup** .](1475-925X-11-88-5){#F5}

The design of CCD camera holder is shown in Figure [6](#F6){ref-type="fig"}. The virtual center line (axis) of CCD camera was fitted particularly to be on the center of the horizontal plane, exactly at intersecting point with the needle tip.

![**Geometrical design of CCD camera holder** .](1475-925X-11-88-6){#F6}

The CCD camera holder was painted by black color to reduce the effect of the outside light. The clinic lights were turned off during the examination. All the apparatus were placed on a small portable hospital cart as shown in Figure [7](#F7){ref-type="fig"} to move it easily in the patient examination room.

![**The implemented OIR laser system for skin cancerous examination** .](1475-925X-11-88-7){#F7}

Work procedure
--------------

The lesion and adjacent healthy area were identified and marked by the dermatologist visually with aid of special lenses.

Placing the special holder tube, Figure [6](#F6){ref-type="fig"}, on the lesion (without pressing) then using the \"c\" character on the computer keyboard five times to capture five diffused reflected profile images for the suspension lesion while continuously running the laser, this procedure takes about three seconds. Then we repeat this procedure for the adjacent healthy area.

By using \"c\" character ( capture command ) on the keyboard the computer will collect the raw data from the CCD camera and import it directly to Matlab program directory folder for analysis.

The measurements are repeated five times in order to average the optical properties for each of lesion and healthy skin.

The optical examination for skin cancer diagnosis was carried on by the sequence shown in Figure [8](#F8){ref-type="fig"}.

![**Work procedure block diagram** .](1475-925X-11-88-8){#F8}

Figure [9A](#F9){ref-type="fig"} shows a sample of the diffused reflected image of case no. 08 in Table [1](#T1){ref-type="table"}, it was a low grade malignancy cancer, its relative diffused reflectance curve resulted by the Matlab program computations is shown in Figure [9B](#F9){ref-type="fig"}.

![**Diffused reflected images for both lesion and healthy adjacent skin area, with their relative diffuse reflectance curves of case no. 08 in Table**[1](#T1){ref-type="table"} .](1475-925X-11-88-9){#F9}

###### 

Results of the 50 cases

   **Case No**   **Patient age and Gender**   **Lesion site**   **Skin lesion optical parameters**   **Healthy adjacent skin optical parameters**   **Matlab logical prediction**   **Histological diagnosis (biopsy results )**                                   
  ------------- ---------------------------- ----------------- ------------------------------------ ---------------------------------------------- ------------------------------- ---------------------------------------------- --------- ---------------------- --------
        1                  Female                   30                        Cheek                                     6.1033                                 0.4132                                  2.5565                      0.0013    Low grade Malignancy    SCC
        2                  Female                   45                        Breast                                    4.9191                                 0.2588                                  3.0221                      0.0011    Low grade Malignancy    SCC
        3                   Male                    60                        Cheek                                    20.1398                                 0.4108                                  2.1211                      0.0016         Malignant          SCC
        4                   Male                    65                        Cheek                                    40.4127                                 0.2058                                  3.1488                       0.147         Malignant          BCC
        5                   Male                    53                        Cheek                                    19.3786                                 0.4267                                  3.2852                      0.1208         Malignant          BCC
        6                   Male                    72                        Cheek                                    13.9541                                 0.5949                                  2.0975                      0.0016         Malignant          BCC
        7                   Male                    42                        Cheek                                     2.0559                                 0.0603                                  2.3434                      0.0014           Benign          Benign
        8                   Male                    46                        Cheek                                     5.787                                  0.3832                                  3.5257                      0.1475    Low grade Malignancy    SCC
        9                   Male                    35                        Cheek                                     5.4704                                 0.3384                                  3.6193                       0.163    Low grade Malignancy    SCC
       10                   Male                    40                         Leg                                      4.6936                                 0.2308                                  3.9528                      0.1708           Benign          Benign
       11                   Male                    32                       Shoulder                                  10.0599                                 0.8058                                  3.1776                      0.1181         Malignant          SCC
       12                   Male                    53                        Cheek                                     12.453                                  0.857                                  2.9346                      0.2001         Malignant          SCC
       13                   Male                    36                        Chest                                     3.9242                                 0.8634                                  2.0341                      0.0321    Low grade Malignancy   Benign
       14                   Male                    48                        Cheek                                     7.963                                  0.1765                                  2.9361                      0.1451         Malignant          SCC
       15                  Female                   47                        Cheek                                     6.5169                                 0.6583                                  2.5561                      0.1239    Low grade Malignancy    SCC
       16                   Male                    43                        Cheek                                     4.3421                                 0.6342                                  2.3692                      0.0056    Low grade Malignancy   Benign
       17                   Male                    38                        Cheek                                     7.5231                                 0.3541                                  3.4321                      0.0239         Malignant          SCC
       18                   Male                    58                        Cheek                                     5.0145                                 0.8001                                  3.0189                      0.0098    Low grade Malignancy   Benign
       19                   Male                    40                        Cheek                                     12.341                                 0.4271                                  3.0341                      0.0785         Malignant          BCC
       20                   Male                    46                        Cheek                                    12.4521                                 0.8765                                  3.1452                      0.0231         Malignant          BCC
       21                   Male                    48                        Chest                                     11.349                                 0.5023                                  3.0231                      0.1228         Malignant          SCC
       22                  Female                   45                        Cheek                                    10.7432                                 0.3923                                  2.9313                      0.3817         Malignant          BCC
       23                   Male                    39                       Shoulder                                   3.7213                                 0.2301                                  2.9736                      0.2001           Benign          Benign
       24                   Male                    51                        Cheek                                     5.8123                                 0.0969                                  2.3847                      0.0185    Low grade Malignancy    SCC
       25                   Male                    35                        Cheek                                     9.1723                                 0.7453                                  2.8376                      0.2387         Malignant          SCC
       26                  Female                   46                        Cheek                                    11.3729                                  0.813                                  3.0062                      0.1078         Malignant          BCC
       27                   Male                    42                        Cheek                                     3.6791                                 0.2338                                  2.4312                      0.0132           Benign          Benign
       28                   Male                    54                        Chest                                     3.9183                                 0.5279                                  2.7128                      0.1761           Benign          Benign
       29                  Female                   35                        Breast                                    5.2871                                 0.2381                                  3.1829                      0.0301    Low grade Malignancy   Benign
       30                  Female                   41                        Chest                                     4.5382                                 0.2473                                  3.0031                      0.1383           Benign          Benign
       31                   Male                    50                        Cheek                                     8.7812                                 0.3482                                  2.4932                      0.0762         Malignant          BCC
       32                   Male                    61                        Cheek                                     6.8231                                 0.4872                                  3.0045                      0.0392    Low grade Malignancy    SCC
       33                   Male                    42                        Cheek                                     7.5237                                 0.2367                                  2.4832                      0.1289         Malignant          SCC
       34                   Male                    63                       Shoulder                                  12.3287                                 0.4287                                  3.2761                      0.2313         Malignant          SCC
       35                  Female                   39                        Cheek                                     3.3231                                 0.1293                                  2.0213                      0.0092           Benign          Benign
       36                   Male                    53                       Forearm                                   10.2382                                 0.3981                                  4.2619                      0.0312         Malignant          SCC
       37                   Male                    38                        Cheek                                    11.2621                                 0.2761                                  3.0123                      0.0927         Malignant          BCC
       38                   Male                    43                        Cheek                                     5.9127                                 0.3327                                  2.0128                      0.0327    Low grade Malignancy    SCC
       39                  Female                   29                        Cheek                                     4.1281                                 0.0912                                  2.5321                      0.0029           Benign          Benign
       40                  Female                   48                        Cheek                                     6.2632                                 0.2642                                  2.9327                      0.1234    Low grade Malignancy    SCC
       41                   Male                    45                        Cheek                                     9.4753                                 0.3424                                  3.4842                      0.2013         Malignant          BCC
       42                   Male                    38                         Arm                                     10.3872                                 0.2345                                  2.9478                      0.0231         Malignant          SCC
       43                   Male                    56                        Cheek                                    12.3473                                 0.1283                                  2.8184                      0.0281         Malignant          SCC
       44                   Male                    47                        Cheek                                    18.4732                                 0.4328                                  3.045                       0.0294         Malignant          BCC
       45                  Female                   34                        Chest                                     6.3424                                 0.1384                                  3.3412                      0.0634    Low grade Malignancy    SCC
       46                   Male                    44                         Leg                                     13.4721                                 0.3714                                  3.1348                      0.1392         Malignant          BCC
       47                   Male                    37                        Cheek                                     6.0313                                 0.3591                                  3.2467                      0.0482    Low grade Malignancy    SCC
       48                  Female                   46                        Cheek                                     4.2485                                 0.1439                                  2.3411                      0.0927    Low grade Malignancy   Benign
       49                   Male                    33                        Cheek                                     4.4553                                 0.1943                                  3.0183                      0.0046           Benign          Benign
       50                   Male                    58                        Cheek                                     7.2384                                 0.3872                                  2.8274                      0.06289        Malignant          SCC

For the same patient case no. 08 in Table [1](#T1){ref-type="table"}, Figures [9C](#F9){ref-type="fig"} and [9](#F9){ref-type="fig"}D show the diffuse reflected image of the healthy adjacent skin area and its relative diffused reflectance curve resulted by the Matlab program computations respectively.

Results and discussion
======================

The results are tabulated for fifty examined cases presented in Table [1](#T1){ref-type="table"}. Our experimental non-invasive logical prediction decision, beside the invasive biopsy analysis result is shown in the table as well as the optical parameters of the lesion and the healthy skins for each patient. Figures [10](#F10){ref-type="fig"} and [11](#F11){ref-type="fig"} show the optical properties of the all fifty cases.

![**Lesion and healthy skin scattering coefficients of the all 50 cases** .](1475-925X-11-88-10){#F10}

![**Lesion and Healthy skin absorption coefficients of the all 50 cases** .](1475-925X-11-88-11){#F11}

This OIDR setup required at least 8 bit of dynamic range of CCD camera to measure the diffuse reflectance within a few centimeters radius of diffused reflectance image, without bring the CCD camera in saturation state.

The accuracy of Δx shift value measurement was proportional to the resolution of the CCD camera in the setup. In our study, the size of pixel was 0.05 mm/pixel and the CCD camera dynamic range was 16 bit.

The sharpness and Δx measurement accuracy of the diffused reflected images, as were shown in Figures [9A](#F9){ref-type="fig"} and [9](#F9){ref-type="fig"}C, increased after painting the camera holder tube black.

The 620 -- 670 *nm* visible light range is better for these applications than the UV and IR. A red 650 *nm* diode laser was selected for these measurements due to its low absorption in the high scattering epidermal tissue, which increased the accuracy of the measured optical properties. While using a green laser of 532 *nm* wavelength to check this phenomena shows that the reflectance at 532 *nm* was below the sensitivity of the CCD camera system.

The diagnostic logical decisions in Table [1](#T1){ref-type="table"} was based on the μ~s~\' threshold value selection beside the increment in the μ~a~ value, Figure [12](#F12){ref-type="fig"} shows the decision rule flow chart for the 50 patients. If the difference value between the scattering coefficient of lesion and the scattering coefficient of healthy adjacent skin greater than or equal to 1.8 cm^-1^ and less than or equal to 4 cm^-1^ and combined with a small increment in the absorption coefficient of lesion over the absorption coefficient of normal healthy adjacent skin, then this lesion will be considered as a low grade malignancy lesion case.

![**Decision rule flow chart** .](1475-925X-11-88-12){#F12}

The threshold value (1.8 cm^-1^) was chosen according to case no. (09) in Table [1](#T1){ref-type="table"}, which is of a 35 year male with lesion in the cheek. The biopsy result was low grade malignant and the difference between the reduced scattering coefficient of lesion and adjacent healthy skin was 1.8511 cm^-1^.

While, the threshold value 4 cm^-1^ was chosen according to case no. (15) in Table [1](#T1){ref-type="table"}, 47 year female with lesion in the cheek, the biopsy result was low grade malignant and the difference between the reduced scattering coefficient of lesion and normal healthy adjacent skin was 3.9608 cm^-1^.

Therefore, the low grade malignancy threshold considered to be ranged from 1.8 cm^-1^ to 4 cm^-1^ .

If the difference value between the scattering coefficient of lesion and the scattering coefficient of healthy adjacent skin less than 1.8 cm^-1^ and combined with a small increment in the absorption coefficient of lesion over the absorption coefficient of normal healthy adjacent skin, then this lesion will be considered as a benign lesion case.

If the difference value between the scattering coefficient of lesion and the scattering coefficient of healthy adjacent skin greater than 4 cm^-1^ and combined with a small increment in the absorption coefficient of lesion over the absorption coefficient of normal healthy adjacent skin, then this lesion will be considered as a malignant lesion case.

Statistically, there are 36 cancerous patients (based on biopsy result) ware predicted positive by our test, these true positive (TP) patients cases represent 72% of all 50 cases.

While, Five non-cancerous lesion patients (based on biopsy result) ware predicted positive by our test, these *false positive* (FP) patients cases represent 10% of all 50 cases.

Nine non-cancerous lesion patients (based on biopsy result) ware predicted negative by our test, these *true negative* (TN) patients cases represent 18% of all 50 cases.

Finally, all patients predicted negative on our test ware diagnosed negative (based on biopsy result), therefore there is no *false negative* (FN) in our procedure. This was accomplished by choosing the precise (1.8 cm^-1^) threshold value.

Proportion of 9 cases that tested negative (TN) of all the 14 patients that actually are negative (TN+FP) represent *the Specificity* (TNR) of our prediction which it 64.62% (With higher specificity, fewer suspected lesion patients are labeled as cancerous).

While, *the Sensitivity* (TPR) of our prediction results is 100% (its represent the probability that our test is positive given that the patient has a cancer), this was accomplished by having no false negative (FN) cases. Table [2](#T2){ref-type="table"} shows the statistical results.

###### 

Statistical results of the 50 cases

  -------------------------------------------------------------- -------- -----------------------
  Statistic Item                                                 Result   Notes

  True positive (TP)                                             36       72% of all 50 cases

  False positive (FP)                                            5        10% of all 50 cases

  True negative (TN)                                             9        18% of all 50 cases

  False negative (FN)                                            Zero     0.00% of all 50 cases

  Specificity (TNR)                                              64.62%   = TN/(TN+FP)

  Sensitivity (TPR)                                              100%     = TP/(TP+FN)

  The positive prediction value (PPV)\                           87.8%    = TP/(TP+FP)
  the proportion of true positives out of all positive results            

  The Negative prediction value (NPV)\                           100%     = TN/(TN+FN)
  the proportion of true positives out of all positive results            

  Accuracy of our predictive measurements (ACC)                  90%      ACC= (TP+TN)/(P+N)\
                                                                          Where; P = (TP+FN)\
                                                                          N = (FP+TN)
  -------------------------------------------------------------- -------- -----------------------

Patients cases no. (13, 16, 18, 29, and 48) in Table [1](#T1){ref-type="table"} were predicted by the Matlab logical prediction as a \"low grade malignancy\", while the patients histological examination (biopsy result) show negative result for malignancy behavior, these false positive (FP) cases are appeared because the difference value between the reduced scattering coefficient of lesion and normal healthy adjacent skin being close to 1.8 cm^-1^.

Figure [13](#F13){ref-type="fig"} shows the results of Matlab logical prediction with two lines of the scattering threshold that represent sensitivity zone of low grade malignancy, the yellow points represent the low grade malignancy cases, the red points represent the malignancy cases, while the blue points represent the benign lesion cases.

![Sensitivity of scattering difference between lesion and healthy skin](1475-925X-11-88-13){#F13}

Low grade malignancy decision by our system is a critical decision, because it depend on the experience of the physicians to see the value of the difference between the normal and lesion optical properties, as shown in Figure [13](#F13){ref-type="fig"}. When the difference between normal and healthy of μ~s~\' is close to 4 cm^-1^ threshold value, the physician must expect the malignancy behavior of the tested lesion and send the patient to perform a histological examination to be sure about the diagnosis. While, if the difference between normal and healthy of μ~s~\' is close to 1.8 cm^-1^ threshold value, the physician must expect the benign behavior of the tested lesion.

The threshold value used to eliminate the false negative (FN) diagnosis, e.g. if we change the threshold (difference) value 1.8 cm^-1^ to be 1.9 cm^-1^, this will produce a false negative diagnosis in case no. (02).

Conclusions
===========

Only the relative profile of the diffuse reflectance was used for the extraction of optical properties, which made the device insensitive to variations of some system parameters such as intensity of the laser source.

The accuracy of Matlab logical prediction result depends on the image analysis and fitting accuracy to obtain optical properties of lesion and adjacent healthy skins, These results in turns depend on many factors such as the light source wavelength, resolution of CCD camera, and the procedure of estimating the center of the circles and determining the Δx shift, as well as the chosen μ~s~\' threshold value.

The overall accuracy of a our predictive measurements is 90% which represent the degree of closeness of our predictive measurements to the actual (true) diagnoses of suspected lesion, see Table [2](#T2){ref-type="table"}.

The common site of SCC and BCC is on the face, therefore it was important to measure the accuracy of the method with respect to the lesion site, the accuracy of the measurements was 91.6% for all lesions that are on the cheek, Table [3](#T3){ref-type="table"}. The mean value of the reduced scattering coefficient for the healthy cheek skin is 2.8 cm^-1^, that have the statistical variance of 0.1842, and the standard deviation of 0.4292 cm^-1^.

###### 

The lesions that are on the cheek

                                       **No.**                                       **Case No**   **Patient age and Gender**   **Lesion Site**   **Skin lesion optical parameters**   **Healthy adjacent skin optical parameters**   **Matlab logical prediction**   **Histological diagnosis (biopsy results )**                                   
  --------------------------------------------------------------------------------- ------------- ---------------------------- ----------------- ------------------------------------ ---------------------------------------------- ------------------------------- ---------------------------------------------- --------- ---------------------- --------
                                          1                                               1                  Female                   30                        Cheek                                     6.1033                                 0.4132                                  2.5565                      0.0013    Low grade Malignancy    SCC
                                          2                                               3                   Male                    60                        Cheek                                    20.1398                                 0.4108                                  2.1211                      0.0016         Malignant          SCC
                                          3                                               4                   Male                    65                        Cheek                                    40.4127                                 0.2058                                  3.1488                       0.147         Malignant          BCC
                                          4                                               5                   Male                    53                        Cheek                                    19.3786                                 0.4267                                  3.2852                      0.1208         Malignant          BCC
                                          5                                               6                   Male                    72                        Cheek                                    13.9541                                 0.5949                                  2.0975                      0.0016         Malignant          BCC
                                          6                                               7                   Male                    42                        Cheek                                     2.0559                                 0.0603                                  2.3434                      0.0014           Benign          Benign
                                          7                                               8                   Male                    46                        Cheek                                     5.787                                  0.3832                                  3.5257                      0.1475    Low grade Malignancy    SCC
                                          8                                               9                   Male                    35                        Cheek                                     5.4704                                 0.3384                                  3.6193                       0.163    Low grade Malignancy    SCC
                                          9                                              12                   Male                    53                        Cheek                                     12.453                                  0.857                                  2.9346                      0.2001         Malignant          SCC
                                         10                                              14                   Male                    48                        Cheek                                     7.963                                  0.1765                                  2.9361                      0.1451         Malignant          SCC
                                         11                                              15                  Female                   47                        Cheek                                     6.5169                                 0.6583                                  2.5561                      0.1239    Low grade Malignancy    SCC
                                         12                                              16                   Male                    43                        Cheek                                     4.3421                                 0.6342                                  2.3692                      0.0056    Low grade Malignancy   Benign
                                         13                                              17                   Male                    38                        Cheek                                     7.5231                                 0.3541                                  3.4321                      0.0239         Malignant          SCC
                                         14                                              18                   Male                    58                        Cheek                                     5.0145                                 0.8001                                  3.0189                      0.0098    Low grade Malignancy   Benign
                                         15                                              19                   Male                    40                        Cheek                                     12.341                                 0.4271                                  3.0341                      0.0785         Malignant          BCC
                                         16                                              20                   Male                    46                        Cheek                                    12.4521                                 0.8765                                  3.1452                      0.0231         Malignant          BCC
                                         17                                              22                  Female                   45                        Cheek                                    10.7432                                 0.3923                                  2.9313                      0.3817         Malignant          BCC
                                         18                                              24                   Male                    51                        Cheek                                     5.8123                                 0.0969                                  2.3847                      0.0185    Low grade Malignancy    SCC
                                         19                                              25                   Male                    35                        Cheek                                     9.1723                                 0.7453                                  2.8376                      0.2387         Malignant          SCC
                                         20                                              26                  Female                   46                        Cheek                                    11.3729                                  0.813                                  3.0062                      0.1078         Malignant          BCC
                                         21                                              27                   Male                    42                        Cheek                                     3.6791                                 0.2338                                  2.4312                      0.0132           Benign          Benign
                                         22                                              31                   Male                    50                        Cheek                                     8.7812                                 0.3482                                  2.4932                      0.0762         Malignant          BCC
                                         23                                              32                   Male                    61                        Cheek                                     6.8231                                 0.4872                                  3.0045                      0.0392    Low grade Malignancy    SCC
                                         24                                              33                   Male                    42                        Cheek                                     7.5237                                 0.2367                                  2.4832                      0.1289         Malignant          SCC
                                         25                                              35                  Female                   39                        Cheek                                     3.3231                                 0.1293                                  2.0213                      0.0092           Benign          Benign
                                         26                                              37                   Male                    38                        Cheek                                    11.2621                                 0.2761                                  3.0123                      0.0927         Malignant          BCC
                                         27                                              38                   Male                    43                        Cheek                                     5.9127                                 0.3327                                  2.0128                      0.0327    Low grade Malignancy    SCC
                                         28                                              39                  Female                   29                        Cheek                                     4.1281                                 0.0912                                  2.5321                      0.0029           Benign          Benign
                                         29                                              40                  Female                   48                        Cheek                                     6.2632                                 0.2642                                  2.9327                      0.1234    Low grade Malignancy    SCC
                                         30                                              41                   Male                    45                        Cheek                                     9.4753                                 0.3424                                  3.4842                      0.2013         Malignant          BCC
                                         31                                              43                   Male                    56                        Cheek                                    12.3473                                 0.1283                                  2.8184                      0.0281         Malignant          SCC
                                         32                                              44                   Male                    47                        Cheek                                    18.4732                                 0.4328                                  3.045                       0.0294         Malignant          BCC
                                         33                                              47                   Male                    37                        Cheek                                     6.0313                                 0.3591                                  3.2467                      0.0482    Low grade Malignancy    SCC
                                         34                                              48                  Female                   46                        Cheek                                     4.2485                                 0.1439                                  2.3411                      0.0927    Low grade Malignancy   Benign
                                         35                                              49                   Male                    33                        Cheek                                     4.4553                                 0.1943                                  3.0183                      0.0046           Benign          Benign
                                         36                                              50                   Male                    58                        Cheek                                     7.2384                                 0.3872                                  2.8274                      0.06289        Malignant          SCC
   The mean value of the reduced scattering coefficient for the healthy cheek skin     100.988                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                       2.8052222                                                         
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